Capital One initiated coverage of Immunocore with an Overweight rating and $84 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IMCR:
- Immunocore price target raised to $91 from $85 at BTIG
- Immunocore price target raised to $75 from $72 at Oppenheimer
- Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
- Immunocore reports Q2 EPS (37c), consensus (41c)
- Immunocore to report second quarter 2023 financial results and host call on August 10, 2023